Xeris Biopharma Holdings (XERS) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

XERS is expected to report earnings to fall 21.70% to -7 cents per share on November 07

Xeris Biopharma Holdings XERS Stock Earnings Reports

Q3'24

Est.

$-0.08

Q2'24

Est.

$-0.10

Q1'24

Missed

by $0.04

Q4'23

Missed

by $0.01

Q3'23

Beat

by $0.01

The last earnings report on August 08 showed earnings per share of -10 cents, missing the estimate of -9 cents. With 1.08M shares outstanding, the current market capitalization sits at 427.63M.

View a ticker or compare two or three

Compare

XERS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For XERS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of ready-to-use, liquid-stable injectables

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

1375 West Fulton Street

Phone

+1 844 445-5704

Employees

377

Web

https://www.xerispharma.com